Resistance to Molecular Therapies for Hepatocellular Carcinoma

door Springer International Publishing
Staat: Nieuw
€ 138,90
Incl. BTW - Gratis verzenden
Springer International Publishing Resistance to Molecular Therapies for Hepatocellular Carcinoma
Springer International Publishing - Resistance to Molecular Therapies for Hepatocellular Carcinoma

Vind je dit product leuk? Verspreid het nieuws!

€ 138,90 incl. btw
Alleen 1 items beschikbaar Alleen 1 items beschikbaar
Levering: tussen donderdag 2 juni 2022 en maandag 6 juni 2022
Verkoop en verzending: Dodax

Andere koopmogelijkheden

1 Aanbieding voor € 151,66

Verkocht door Dodax

€ 151,66 incl. btw
Staat: Nieuw
Geen verzendkosten
Levering: tussen donderdag 2 juni 2022 en maandag 6 juni 2022
Bekijk andere koopmogelijkheden

Omschrijving

This volume evaluates the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold standard to define radiological resistance; describes the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment; determines the role of the cancer stem cell phenotype in resistance; reviews the experimental models to study resistance; and addresses new approaches to overcome resistance to sorafenib, using successful examples from other malignancies.

Productdetails

Opmerking illustraties:
XIII, 147 p. 16 illus. in color.
Inhoudsopgave:
Tumor Heterogeneity and Resistance to Targeted Therapies in Hepatocellular Carcinoma.- Modulating Immune Responses to Overcome Resistance in Hepatocellular Carcinoma.- Role of Tumor Microenvironment in Hepatocellular Carcinoma Resistance.- Contribution of the Cancer Stem Cell Phenotype to Hepatocellular Carcinoma Resistance.- Clinical and Preclinical Perspectives on Mechanisms  of Sorafenib Resistance in Hepatocellular Carcinoma.- Radiological Assessment of Response to Palliative Treatments in Hepatocellular Carcinoma.- Sorafenib and Clinical Patterns of Resistance in hepatocellular carcinoma.- Overcoming Treatment Resistance in Hepatocellular Carcinoma: regorafenib and lessons from other malignancies.




Uitgever:
Villanueva, Augusto;Villanueva
Opmerkingen:
This book will evaluate the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold-standard to define radiological resistance


This book will describe the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment


This book will help determine the role of the cancer stem cell phenotype in resistance


This book will review the experimental models to study resistance


This book will address new approaches to overcome resistance to sorafenib, using successful examples from other malignancies

Mediatype:
Hardcover
Uitgever:
Springer International Publishing
Biografie:
Augusto Villanueva, MD, PhD, is Assistant Professor, Division of Liver Diseases, Liver Cancer Program, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine, NYC.
Taal:
Engels
Versie:
1st ed. 2017
Aantal pagina’s:
147

Basisgegevens

Product Type:
Boek gebonden
Afmetingen pakket:
0.241 x 0.16 x 0.015 m; 0.4 kg
GTIN:
09783319561967
DUIN:
MPHLDOALLJ8
€ 138,90
We gebruiken cookies op onze website om onze diensten efficiënter en gebruiksvriendelijker te maken. Selecteer daarom "Accepteer cookies"! Lees ons Privacybeleid voor meer informatie.